Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013
- 1 August 2015
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 29 (6), 858-869
- https://doi.org/10.1016/j.bpobgyn.2015.03.006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Through the glass darkly: intraepithelial neoplasia, top‐down differentiation, and the road to ovarian cancerThe Journal of Pathology, 2013
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological featuresVirchows Archiv, 2012
- Rethinking ovarian cancer: recommendations for improving outcomesNature Reviews Cancer, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Ovarian carcinoma pathology and genetics: recent advancesHuman Pathology, 2009
- Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk ReductionJournal of Clinical Oncology, 2007
- Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal RelationshipThe American Journal of Surgical Pathology, 2007
- Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian CarcinogenesisThe American Journal of Surgical Pathology, 2005
- Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous CarcinomaJNCI Journal of the National Cancer Institute, 2003
- Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancerThe Journal of Pathology, 2001